Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Rui Fang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6075-9201; OpenAlex author ID A5022399844. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 6

  1. PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.celrep.2025.115541↗
  2. An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial. Co-author DOI 10.1186/s12943-025-02406-7↗
  3. Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer. Co-author DOI 10.1038/s41467-024-54975-8↗
  4. Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression. Co-author DOI 10.1038/s41467-021-27088-9↗
  5. FASTKD2 promotes cancer cell progression through upregulating Myc expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jcb.29468↗
  6. PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer. First author DOI 10.1186/s13046-019-1466-7↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jens Thomas Siveke · 4 shared papers, 2022–2025 · strength 0.65
  2. Phyllis F. Cheung · 3 shared papers, 2022–2025 · strength 0.45
  3. Smiths Lueong · 2 shared papers, 2022–2025 · strength 0.30
  4. Tao Liu · 2 shared papers, 2019–2020 · strength 0.25
  5. Xin Jin · 2 shared papers, 2019–2020 · strength 0.25
  6. Marija Trajkovic‐Arsic · 1 shared paper, 2025 · strength 0.20
  7. Madeleine Dorsch · 1 shared paper, 2025 · strength 0.20
  8. Hendrik Schürmann · 1 shared paper, 2025 · strength 0.20
  9. Stephan A. Hahn · 1 shared paper, 2025 · strength 0.20
  10. Barbara M. Grüner · 1 shared paper, 2025 · strength 0.20
  11. Laura Godfrey · 1 shared paper, 2025 · strength 0.20
  12. Ben Zhao · 1 shared paper, 2025 · strength 0.20
  13. Tim Eiseler · 1 shared paper, 2025 · strength 0.19
  14. Andrea Tannapfel · 1 shared paper, 2025 · strength 0.19
  15. Thomas Jens Ettrich · 1 shared paper, 2025 · strength 0.19
  16. Anton Lahusen · 1 shared paper, 2025 · strength 0.19
  17. Meinolf Karthaus · 1 shared paper, 2025 · strength 0.19
  18. Manfred Paul Lutz · 1 shared paper, 2025 · strength 0.19
  19. Alexander Kleger · 1 shared paper, 2025 · strength 0.19
  20. Thomas Theodor Werner Seufferlein · 1 shared paper, 2025 · strength 0.19
  21. Albrecht Stenzinger · 1 shared paper, 2025 · strength 0.19
  22. Diana Behrens · 1 shared paper, 2024 · strength 0.16
  23. Francesca Lupo · 1 shared paper, 2024 · strength 0.16
  24. Vincenzo Corbo · 1 shared paper, 2024 · strength 0.16
  25. Antonio Agostini · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.